99 related articles for article (PubMed ID: 38509894)
1. Exploring the metastasis-related biomarker and carcinogenic mechanism in liver cancer based on single cell technology.
Zheng Q; Lu C; Yu L; Zhan Y; Chen Z
Heliyon; 2024 Mar; 10(6):e27473. PubMed ID: 38509894
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1
Liang Y; Zhong D; Yang Q; Tang Y; Qin Y; Su Y; Huang X; Shang J
J Hepatocell Carcinoma; 2024; 11():373-383. PubMed ID: 38410699
[TBL] [Abstract][Full Text] [Related]
4. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.
Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M
Nucleosides Nucleotides Nucleic Acids; 2024 Feb; ():1-16. PubMed ID: 38319987
[TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.
Han C; Chen J; Huang J; Zhu R; Zeng J; Yu H; He Z
Front Oncol; 2023; 13():1104262. PubMed ID: 36860314
[TBL] [Abstract][Full Text] [Related]
6. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress.
Lu Y; Chan YT; Wu J; Feng Z; Yuan H; Li Q; Xing T; Xu L; Zhang C; Tan HY; Lee TK; Feng Y; Wang N
Drug Resist Updat; 2023 Nov; 71():101015. PubMed ID: 37924725
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced the upregulation of NDUFA4L2 promoted colon adenocarcinoma progression through ROS-mediated PI3K/AKT pathway.
Ye N; Wang Y; Jiang P; Jiang H; Ding W; Zhang Z; Xi C
Cytotechnology; 2023 Dec; 75(6):461-472. PubMed ID: 37841958
[TBL] [Abstract][Full Text] [Related]
9. Ras homolog family member J (RHOJ): a key regulator of chemoresistance associated with epithelial-mesenchymal transition.
Liu S; Ren J; Zhang L
Signal Transduct Target Ther; 2023 Oct; 8(1):376. PubMed ID: 37779170
[No Abstract] [Full Text] [Related]
10. Comprehensive intratumoral heterogeneity landscaping of liver hepatocellular carcinoma and discerning of APLP2 in cancer progression.
Tao Z; Huang J; Li J
Environ Toxicol; 2024 Feb; 39(2):612-625. PubMed ID: 37515494
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies.
Jia W; Huang Z; Zhou L; Liou YC; Di Virgilio F; Ulrich H; Illes P; Zhang W; Huang C; Tang Y
Drug Resist Updat; 2023 Sep; 70():100988. PubMed ID: 37413937
[TBL] [Abstract][Full Text] [Related]
12. NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.
Kubala JM; Laursen KB; Schreiner R; Williams RM; van der Mijn JC; Crowley MJ; Mongan NP; Nanus DM; Heller DA; Gudas LJ
Cancer Biol Ther; 2023 Dec; 24(1):2170669. PubMed ID: 36722045
[TBL] [Abstract][Full Text] [Related]
13. [An update of understanding of the hepatic vascular system and new research strategies].
Lin Y; Liu Z; Dong M; Zhou W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1907-1911. PubMed ID: 36651262
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
